Robotic Exoskeleton Assisted Gait Post Stroke

Part of paid clinical trials in West Orange, New Jersey.

Sponsor
Kessler Foundation
Study ID
NCT04309305
Phase
PHASE1
Status
Enrolling By Invitation

Conditions

  • CVA
  • Gait, Hemiplegic

Eligibility Criteria

Sex
ALL
Age
21 Years - 80 Years
Healthy Volunteers
Accepted

Interventions

  • EksoGT™, Ekso Bionics, Berkley, CA, USA — DEVICE
    The Robotic Exoskeleton is a device that will be strapped to the chest and legs and worn over the shoulders like a backpack that will assist in walking.
  • Standard of Care — OTHER
    Standard gait therapy provided by licensed physical therapists post stroke.
  • No Intervention — OTHER
    Testing Only

Study Details

The current investigation takes advantage of both a progressive and adaptive assist-as-needed massed practice and time-sensitive neuroplasticity through exoskeleton assisted walking in order to induce greater recovery-oriented CNS plasticity and consequent gains in more independent walking.

Key Dates

Start date
Jan 30, 2020
Status verified
Apr 2025
Primary completion
May 1, 2026
Completion
Sep 1, 2026

Study Design

Enrollment
75 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Stroke RE
    After discharge from the acute rehabilitation facility, participants in the stroke RE group will participate 3 days a week for 10 weeks in robotic exoskeleton gait training provided by a trained, licensed physical therapist. Participants will be permitted to participate in additional prescribed standard physical therapy on their own.
  • Active Comparator: Stroke SOC
    After discharge from the acute rehabilitation facility, participants in the stroke SOC group will participate 3 days a week for 10 weeks in standard of care gait training provided by a licensed physical therapist. Participants will be permitted to participate in additional prescribed standard physical therapy on their own.
  • Other: Healthy Control
    Participants in the healthy control group will not participate in any gait training. Healthy control participants will only be asked to complete 3 testing sessions.

Primary Outcome Measure

Functional Independence Measure (FIM) (aim 1) [ Time Frame: Change from Baseline FIM at 10 weeks ]

Locations (1)

FacilityCityStateZIPSite coordinators
Kessler FoundationWest OrangeNew Jersey07052-

Find similar trials in West Orange, NJ

By condition

Related Studies